COST PLUS FIXED FEENO SET ASIDE USED.

PUBLIC HEALTH VACCINES LLC - ADVANCED RESEARCH AND DEVELOPMENT OF RVSV-MARV VACCINE.

PIID: 75A50119C00022

Signed Date: Jan 16, 2026Effective Date: Feb 1, 2019End Date: Closes in 795 days

Award $

$55.5M

Vendor

PUBLIC HEALTH VACCINES LLC

NAICS

541714

Signed Date

Jan 16, 2026

Key Details

Dollars Obligated

$55.5M

Base & All Options

Awarding Agency

Awarding Sub-Agency

Office of Assistant Secretary for Preparedness and Response

NAICS Code

Product Service Code

AN13 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

CAMBRIDGE, MA, 021421272, CD-MA-07

ADVANCED RESEARCH AND DEVELOPMENT OF RVSV-MARV VACCINE.

On Jan 16, 2026, Department of Health and Human Services obligated $55,547,653.76 to PUBLIC HEALTH VACCINES LLC for advanced research and development of rvsv-marv vaccine.. The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a cost plus fixed fee contract. Competition extent: full and open competition with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in CAMBRIDGE, MA. The contract is scheduled through Dec 31, 2028.

Recompete outlook: Ends Dec 31, 2028, in 26 months. Recompete signal as of Oct 17, 2026: 19/100, combining time to the end date, the incumbent's history with this agency, whether the award was competed, and its size.
Competition: Competed, with 1 offer. 96% of 222 awards in this market (Department of Health and Human Services awards in NAICS 541714 over the last 3 years) were competed; median 1 offers.
Award size: At $55.5M, this award is larger than three in four of the 212 priced Department of Health and Human Services awards in NAICS 541714 over the last 3 years (median $1.2M).
Largest vendors in this market: By obligations, Department of Health and Human Services awards in NAICS 541714 over the last 3 years.
TECHNICAL RESOURCES INTERNATIONAL, INC. — 4 awards, $379.6M
ALLUCENT GOVERNMENT SERVICES (US) LLC — 2 awards, $373.2M
ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC. — 4 awards, $342.2M
PARATEK PHARMACEUTICALS, INC — 1 award, $265.3M
GENENTECH INC — 1 award, $243.7M